Lorcaserin Extended-Release Tablets and Pneumococcal polysaccharides vaccine (PPSV), 23-valent
Determining the interaction of Lorcaserin Extended-Release Tablets and Pneumococcal polysaccharides vaccine (PPSV), 23-valent and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: pneumococcal 23-polyvalent vaccine
Brand name: Pneumovax 23
Synonyms: Pneumococcal Polysaccharide Vaccine (23-Valent)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Pneumovax 23
- Lorcaserin Extended-Release Tablets-PNV - Omega
- Lorcaserin Extended-Release Tablets-PNV Iron Polysaccharides, Folic Acid, DHA
- Lorcaserin Extended-Release Tablets-PNV OB with DHA
- Lorcaserin Extended-Release Tablets-PNV Prenatal plus Multivitamin
- Lorcaserin Extended-Release Tablets-PNV Prenatal Vitamins
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent-Lorcaserin Hydrochloride
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent-Lorcaserin Tablets
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent-Lorcet
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent-Lorcet Plus
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent-Lorcet Tablets
- Pneumococcal polysaccharides vaccine (PPSV), 23-valent-Lorlatinib